QAMNURV
LIVE

Serial Number

99371416

Owner

Glaxo Group Limited

Attorney

Elizabeth K. Rucki

Filing Date

Sep 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QAMNURV Trademark

Serial Number: 99371416 • Registration: 8137360

QAMNURV is a trademark filed by Glaxo Group Limited on September 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Glaxo Group Limited (40 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

September 3, 2025

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 21, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 29, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 29, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 29, 2025 CNSL
ASSIGNED TO EXAMINER
Oct 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 3, 2025 MAFR
NEW APPLICATION ENTERED
Sep 3, 2025 NWAP